Articles from Biotech Business (September 1, 2003)

Title	Author	Type	Words
FDA CLEARS SANGSTAT'S TWO HYMOGLOBULIN IND APPLICATIONS.			725
MBI 226 STATISTICAL SUPERIORITY NOT ACHIEVED IN PHASE III.			828
NEWNEURAL CSO GETS NIH GRANT OF $1.4 MILLION.			498
NEXMED DEVELOPING TREATMENT FOR PREMATURE EJACULATION.			442
TRANSFORM DEVELOPING IN VITRO CELL CONTROL METHODOLOGY.			543